US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

64.26

-0.7100-1.09%

Post-market: 64.260.00000.00%19:30 EDT

Volume:52.74K

Turnover:3.38M

Market Cap:91.56M

PE:- -

High:64.61

Open:64.61

Low:63.59

Close:64.97

52wk High:68.00

52wk Low:36.00

Shares:1.42M

Float Shares:1.42M

Volume Ratio:1.40

T/O Rate:3.70%

Dividend:0.65

Dividend Rate:1.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna on Track for Best Month on Record

Early notable gainers among liquid option names on August 25th

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

Binance launches 5 stock perpetuals with 20x leverage

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Illumina management to meet virtually with Piper Sandler

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?

Simply Wall St.

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live

Guardant Health to appeal federal district court judgment in TwinStrand case

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/GNOM/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":64.26,"timestamp":1788552000000,"preClose":64.97,"halted":0,"volume":52741,"hourTrading":{"tag":"盘后","latestPrice":64.26,"preClose":64.26,"latestTime":"19:30 EDT","volume":17477,"amount":1123089.77,"timestamp":1788564603375,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010928120671078864,"floatShares":1424771,"shares":1424771,"eps":0,"marketStatus":"Market Closed","change":-0.71,"latestTime":"09-04 16:00:00 EDT","open":64.61,"high":64.61,"low":63.59,"amount":3383834.60727,"amplitude":0.0157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":64.97,"sharesOutstanding":1094672,"nav":64.98,"aum":92569169.73,"dividendRate":0.01011,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":64.71,"preClose":64.97,"latestTime":"09:29 EDT","volume":800,"amount":51744.00000000001,"timestamp":1788528599042,"change":-0.26,"changeRate":-0.004002,"amplitude":0.001231},"postHourTrading":{"tag":"盘后","latestPrice":64.26,"preClose":64.26,"latestTime":"19:30 EDT","volume":17477,"amount":1123089.77,"timestamp":1788564603375,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.398342377303091,"impliedVol":0.2521,"impliedVolPercentile":0.5992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1424771,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.398342377303091,"shares":1424771,"dividePrice":0.6497,"high":64.61,"amplitude":0.0157,"preClose":64.97,"low":63.59,"week52Low":36,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":64.26,"eps":0,"divideRate":0.01011,"volume":52741,"delay":0,"ttmEps":0,"open":64.61,"prevYearClose":45.4562,"prevWeekClose":64.8066,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":64.8066,"twentyDayClose":58.1737,"sixtyDayClose":47.9179},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662758856","title":"Moderna on Track for Best Month on Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758856?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:00","pubTimestamp":1787666400,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  is currently at $151.90, up $13.01 or 9.37%--On pace for largest percent increase since Aug. 19, 2026, when it rose 176.97%--Currently up three of the past five days--Up 177.09% month-to-date; on pace for best month on record --Up 415.09% year-to-date--Down 68.65% from its all-time closing high of $484.47 on Aug. 9, 2021--Up 514.23% from 52 weeks ago , when it closed at $24.73--Down 12.89% from its 52-week closing high of $174.38 on Aug. 19, 2026--Up 579.34% from its 52-week closing low of $22.36 on Nov. 20, 2025--Traded as high as $154.27--Up 11.07% at today's intraday high--Best performer in the S&P 500 today--Fifth most active stock in the S&P 500 todayAll data as of 9:57:26 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","MRNX","BK4568","IDNA","BK4585","LGHT","MRNA","MRNY","BK4588","BK4533","BK4532","GNOM","WDNA","BK4548","BK4501","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758844","title":"Early notable gainers among liquid option names on August 25th","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758844?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:55","pubTimestamp":1787666119,"startTime":"0","endTime":"0","summary":"Notable gainers among liquid option names this morning include Moderna (MRNA) $153.72 +14.83, Super Micro (SMCI) $37.78 +2.61, Marvell (MRVL) $245....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0187121727.USD","BK4533","LU2931357623.SGD","IE0004086264.USD","LU1235294995.USD","IE00BMPRXQ63.HKD","MRNA","LU1548497426.USD","QQQA","LGHT","LU1169590202.USD","FTXL","MRNY","LU1989764664.SGD","SG9999000418.SGD","BK4588","WUGI","BK4605","LU0274383776.USD","SMCX","LU1992135399.USD","LU2458330169.SGD","SMCC","LU0642271901.SGD","ARTY","LU1046421795.USD","IE00BMPRXR70.SGD","LU0154236417.USD","LU1720051108.HKD","FXL","SOXY","LU0823421333.USD","BK4141","LU0127658192.USD","SMCI","BK4515","BK4534","BK4139","BK4170","MRNX","BK4604","LU0056508442.USD","LU2272731865.HKD","DTCR","LU0444971666.USD","SMCZ","FAI","LU0957808578.USD","LU2272731600.USD","LU1169589451.USD","GNOM","LU1720051017.SGD","XNTK","LU1815336760.USD","LU1303367103.USD","BK4551","AIFD","LU2360107168.USD","IE00BBT3K403.USD","IE0004091025.USD","BK4501","LU0823434740.USD","MRVU","LU0053671581.USD","LU1316542783.SGD","LU2473716301.USD","BK4548","LU1989764748.USD","IDNA","SMYY","SMCL","MRVL","BK4532","LU2357305700.SGD","AIS","LU2272731782.SGD","MRVX","LU1119994496.HKD","LU2322448791.USD","LU2322448957.HKD","BK4581","LU0444973449.USD","IE00BMPRXN33.USD","LU2543165471.USD","FDTX","IE00BLSP4239.USD","LU0823434583.USD","IE00BN8TJ469.HKD","LU1642822529.SGD","LU1823568750.SGD","LU0476273544.USD","LU2290526834.HKD","LU2244417387.USD","LU2458330243.SGD","MVLL","BK4568","IE00BLSP4452.SGD","LU1261432733.SGD","WDNA","BK4543","LU0823421416.USD","LU0786609619.USD","LU1084165304.USD","LU1992135472.HKD","GTEK","BK4585","LU2089985449.USD","LU0061475181.USD","LU1861220033.SGD","SMHX","SMCY","LU2098885051.SGD","LU1861215975.USD","LU0081259029.USD","LU1852331112.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662730978","title":"Moderna Shares up 8.4% as Barclays Hikes Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662730978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662730978?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:44","pubTimestamp":1787665459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4548","BK4551","BK4534","WDNA","BK4568","GNOM","BK4139","BK4588","LGHT","MRNA","MRNX","MRNY","IDNA","BK4501","BK4585","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737518","title":"After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737518","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737518?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:00","pubTimestamp":1787662814,"startTime":"0","endTime":"0","summary":"WSW, NY, August 25th, 2026, FinanceWire Moderna’s cancer news sent its stock up 177% in a single day (NASDAQ:MRNA), from $62.96 to $174.38. Roughly...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TQQY","QLD","ONEQ","MRNA","QQQE","SLXN","BK4139","JEPQ","TQQQ","SQQQ","LGHT",".IXIC","MNQmain","GNOM","GPIQ","BK4501","QQQM","MRNY","QDTE","NDX","BK4534","BK4568","QYLG","BK4585","BK4532","IYW","NVIW.SI","QQQA","QQQ","QQQJ","MRNX","WDNA","BK4548","QQQY","FTEC","BK4533","PSQ","NQmain","BK4588","IDNA","BK4551","TECS","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662336117","title":"Moderna upgraded to Peer Perform from Underperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662336117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662336117?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:46","pubTimestamp":1787651170,"startTime":"0","endTime":"0","summary":"Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target The firm says the positive melanoma trial de-risks ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGHT","BK4501","GNOM","BK4533","IDNA","MRNX","WDNA","BK4548","MRNY","BK4534","BK4532","BK4551","BK4585","MRNA","BK4588","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781125","title":"Binance launches 5 stock perpetuals with 20x leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781125","media":"cryptonews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781125?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:21","pubTimestamp":1787642512,"startTime":"0","endTime":"0","summary":"Binance Futures launched five USDT-margined TradFi perpetual contracts on Aug. 25, giving eligible traders leveraged exposure to Trump Media, Moderna and three semiconductor-focused exchange-traded funds.Binance launched five USDT margined perpetual contracts tied to U.S. stocks and leveraged exchange-traded funds.Contracts offer up to 20x leverage, round-the-clock trading and eight-hour funding settlements through Binance Futures.SKUU and SKDD track daily moves in SK Hynix, while RAM references leveraged DRAM exposure.DJT and MRNA perpetuals reference Trump Media and Moderna shares without granting stock ownership rights.Each contract uses USDT for settlement and requires a minimum notional trade worth five dollars.The contracts began trading at five-minute intervals between 09:00 and 09:20 UTC. Binance listed SKUUUSDT, SKDDUSDT, RAMUSDT, DJTUSDT and MRNAUSDT with maximum leverage of 20x.The long fund seeks twice the daily percentage change in SK Hynix’s U.S.-listed depositary receipt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BK4516","BK4533","BK4568","GNOM","MRNY","SKHU","DRAL","SKHA","07709","BK4585","HYNX","BK4547","MRNX","SKHZ","TRUMP.USD.CC","SKUU","DJT","RAMZ","MRNA","BK4548","SKHX","BK4077","WDNA","BK4532","SK","SKHY","BK4139","DJTU","BK4588","SKDD","DRAM","BK4534","LGHT","IDNA","BK4551","RAM","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137520507","title":"Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning","url":"https://stock-news.laohu8.com/highlight/detail?id=1137520507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137520507?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:02","pubTimestamp":1787630523,"startTime":"0","endTime":"0","summary":"The biotechnology industry is fundamentally driven by clinical milestones—the success or failure of a Phase 3 trial can trigger significant share price swings not only for the companies directly...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK4551","BK4534","BK4568","LGHT","159646","XLK","MRNA","IDNA","BK4532","BK4533","BK4588","BK4501","BK4585","WDNA","BK4139","BK4548","MRNX","MRNY","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020952","title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020952","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020952?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:22","pubTimestamp":1787606549,"startTime":"0","endTime":"0","summary":"Guardant Health Co-CEO AmirAli Talasaz disposes of USD 6.35 million in common sharesGuardant Health Co-CEO AmirAli Talasaz sold 37,500 common shares on Aug. 21, 2026 through the Talasaz Family Foundat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9NSL6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","GH","LU0109394709.USD","HELX","PTH","GDOC","LU0320765992.SGD","EKG","GNMX","LFSC","LU0889565916.HKD","BK4588","FFOX","BK4196","GNOM","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662357209","title":"Illumina management to meet virtually with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2662357209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662357209?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:45","pubTimestamp":1787604320,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held to be held on August 25-26 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, marke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/illumina-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/illumina-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ILMN","LU0029874061.USD","GNMX","BK4588","GNOM","BK4585","BK4535","LU0128526141.USD","BK4548","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","IBBQ","LU1037948541.HKD","LU2089984988.USD","GILD","BIB","IDNA","LU1585245621.USD","SG9999015952.SGD","TBXU","BMED","LU0859254822.USD","LU1061106388.HKD","IE00B19Z3581.USD","IE00B3T34201.USD","LU0114720955.EUR","IE0002270589.USD","BK4566","WDNA","LU0320765992.SGD","BK4578","LU1057294990.SGD","SG9999015986.USD","BK4139","LU0289739699.SGD","MEDI","BK4534","LU1839511570.USD","MRNX","TMED","LU0122379950.USD","LGHT","IBB","IE00BKVL7J92.USD","BK4532","BK4548","GNOM","LU2324357040.USD","MRNY","LU0234570918.USD","BK4568","LU1037948897.HKD","LU0109394709.USD","BBH","LU2468319806.SGD","LU0965509283.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2357627491.SGD","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209693","title":"Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209693","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209693?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:23","pubTimestamp":1787603037,"startTime":"0","endTime":"0","summary":"Natera (NTRA) is back on investor radar after Stanley Druckenmiller's family office made the stock its largest holding. This coincides with strong revenue growth, higher test volumes, and improving free cash flow.\nSee our latest analysis for Natera.\nNatera’s recent news on clinical collaborations and higher test volumes sits alongside strong momentum in the stock. The 30 day share price return of 26.73% and 1 year total shareholder return of 104.36% point to building enthusiasm, while the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/natera-ntra-as-druckenmiller-backs-growth-story-is-the-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/natera-ntra-as-druckenmiller-backs-growth-story-is-the-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171402.SGD","LU2065731478.USD","DCF","LU0963586101.USD","LU0053671581.USD","LU1988902786.USD","LU1064131342.USD","LU2065171311.SGD","LU2264538146.SGD","GNOM","BK4139","LU0345770993.USD","LU2065169927.USD","LU2324357040.USD","LU0345770308.USD","LU0106261612.USD","HELX","LU0012050646.USD","LU2065170008.USD","NTRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205974","title":"Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205974?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:41","pubTimestamp":1787600471,"startTime":"0","endTime":"0","summary":"Guardant Health  said Monday it will appeal the final judgment of a Delaware district court related to a patent infringement dispute with TwinStrand Biosciences and University of Washington.The company said execution of the court's final decision and collection of potential royalties are on hold, pending the appeal.The potential royalties do not apply to the company's current versions of Guardant Reveal and Shield, which feature updated technology. Additionally, the company has made design improvements to Guardant360 that would exclude the impact of potential ongoing royalties.The patents have also been preliminarily invalidated in separate challenges before the US Patent and Trademark Office, the company added.Shares fell around 3.5% in late afternoon trading.Price: 164.62, Change: -6.07, Percent Change: -3.56","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","EKG","GNOM","GH","HELX","BK4196","BK4551","LFSC","LU0109394709.USD","PTH","BK4585","GDOC","GNMX","FFOX","BK4588","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662030912","title":"Guardant Health to appeal federal district court judgment in TwinStrand case","url":"https://stock-news.laohu8.com/highlight/detail?id=2662030912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662030912?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:55","pubTimestamp":1787597714,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced it will appeal the final judgment from the U.S. District Court for the District of Delaware related to intellectual ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4585","BK4196","LFSC","GDOC","LU0320765992.SGD","GNMX","BK4588","LU0889565916.HKD","GH","GNOM","HELX","BK4551","BK4535","FFOX","PTH","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203463","title":"Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203463?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","LU0109394709.USD","BK4535","LU0320765992.SGD","PTH","BK4585","HELX","GH","LFSC","EKG","FFOX","GDOC","GNMX","BK4588","LU0889565916.HKD","GNOM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203434","title":"Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203434","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","GNOM","GDOC","GH","EKG","BK4588","HELX","PTH","LFSC","BK4196","LU0109394709.USD","BK4551","LU0320765992.SGD","LU0889565916.HKD","BK4585","BK4535","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034312","title":"Guardant Health to Appeal Federal District Court Judgment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034312?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","GH","LU0889565916.HKD","HELX","PTH","BK4588","BK4196","LFSC","LU0320765992.SGD","GNMX","FFOX","GDOC","BK4535","EKG","GNOM","BK4551","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035552","title":"Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035552","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035552?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:15","pubTimestamp":1787591724,"startTime":"0","endTime":"0","summary":"• Moderna and Merck announced positive Phase 3 results for their personalized mRNA cancer vaccine.\n• The stock surged significantly before experiencing a pullback driven by profit-taking and valuation resets.\n• Analysts maintained cautious ratings and price targets well below the temporary peak levels.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262128327-market-movers-mrna-20260824","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4588","BK4548","BK4551","BK4533","BK4532","MRNY","MRNA","IDNA","MRNX","BK4501","WDNA","BK4139","BK4534","BK4585","BK4568","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662520885","title":"U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2662520885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662520885?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:55","pubTimestamp":1787590534,"startTime":"0","endTime":"0","summary":"UPDATE 2-U.S. court orders Guardant to pay $245 million in DNA sequencing patent disputeAug 24 (Reuters)-A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Bioscien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L18D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","GNMX","LU0053671581.USD","LU0320765992.SGD","GNOM","EKG","HELX","BK4022","FFOX","LFSC","PTH","BK4551","GH","BK4585","LU2065731478.USD","BK4232","BK4588","GDOC","SAIA","LU0109394709.USD","BK4196","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661285272","title":"Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661285272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661285272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:45","pubTimestamp":1787582700,"startTime":"0","endTime":"0","summary":"Top executives at Moderna have been projecting high confidence in the commercial future of the company's personalized cancer vaccine even as Wall Street holds out for complete trial results.The market","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCC","LU1917777945.USD","LU1037948541.HKD","LU2324357040.USD","IDNA","LU2491050154.USD","MRK","PPH","LU2361045086.USD","RXL","IXJ","LU0058720904.USD","GNOM","IE00BJT1NW94.SGD","VHT","BK4585","FHLC","LU1116320737.USD","BK4501","LU2361044865.SGD","BK4568","JDOC","BK4139","SG9999015358.SGD","FTXH","LU0211331839.USD","LU0208291251.USD","BK4532","LU0203347892.USD","LU0234572021.USD","LU1941712264.USD","MRNY","TRUH","LU1989772923.USD","LU0238689110.USD","LU0868494708.USD","IHE","MRNA","IE00BN8TJ469.HKD","GDOC","IYH","HRTS","BMED","MRNX","XLV","WDNA","LU0320765489.SGD","PAWZ","LGHT","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","JDOC","GNOM","XT","HELX","WDNA","LFSC","SYNB","IDNA","BK4588","BK4585","HTEC","BMED","GDOC","IBB","TMAT","FDIF","MEDX","PBE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}